The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index, and 2 are not checked yet.
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
Open accessAbstract
PPAR gamma is required for fat cell development and is the molecular target of antidiabetic thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal muscle, and liver. Unexpectedly, we found that inactivation of PPAR gamma in macrophages results in the development of significant glucose intolerance plus skeletal muscle and hepatic insulin resistance in lean mice fed a normal diet. This phenotype was associated with increased expression of inflammatory markers and impaired insulin signaling in adipose tissue, muscle, and liver. PPAR gamma-deficient macrophages secreted elevated levels of factors that impair insulin responsiveness in muscle cells in a manner that was enhanced by exposure to FFAs. Consistent with this, the relative degree of insulin resistance became more severe in mice lacking macrophage PPAR gamma following high-fat feeding, and these mice were only partially responsive to TZD treatment. These findings reveal an essential role of PPAR gamma in macrophages for the maintenance of whole-body insulin action and in mediating the antidiabetic actions of TZDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in PPARγ deficient mice exhibit impaired M2 macrophage function and susceptibility to diet-induced inflammation and insulin resistance [29,65–67].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [66]
In the citing paper
“thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
In the citing paper
“Treatment of macrophages with the insulin-sensitizing drugs thiazolidinediones (TZDs), which are PPARγ ligands, polarizes macrophages toward the M2/antiinflammatory state, thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citation
Research works printed but not linked: 3
- Ibrahimi, 1994, Mol. Pharmacol., 46, 1070
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1172/JCI200419528 · DOI
Cited by
Sorted by citations
Items 101–200 of 457
PPAR agonists: multimodal drugs for the treatment of type-2 diabetes
Gross, B. S., & Staels, B. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.09.004 · Cited by 189
Connecting Type 1 and Type 2 Diabetes through Innate ImmunityPreprint
Odegaard, J. I., & Chawla, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007724 · Cited by 188
Ribas, V., Drew, B. G., Le, J., Soleymani, T., Daraei, P., Sitz, D., Mohammad, L., Henstridge, D. C., Febbraio, M. A., Hewitt, S. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104533108 · Cited by 179
Self-citationKhan, I. M., Perrard, X.-Y., Brunner, G., Lui, H., Sparks, L. M., Smith, S. R., Wang, X., Shi, Z.-Z., Lewis, D. E., Wu, H., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.104 · Cited by 182
Xue, B., Yang, Z., Wang, X., & Shi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045990 · Cited by 185
Xie, Z., Hao, H., Tong, C., Cheng, Y., Liu, J., Pang, Y., Si, Y., Guo, Y., Zang, L., Mu, Y., et al. (2015) · Stem Cells · doi:10.1002/stem.2238 · Cited by 178
NCoR Repression of LXRs Restricts Macrophage Biosynthesis of Insulin-Sensitizing Omega 3 Fatty Acids
Li, P., Spann, N. J., Kaikkonen, M. U., Lu, M. M., Oh, D. Y., Fox, J. N., Bandyopadhyay, G. K., Talukdar, S., Xu, J., Lagakos, W., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.054 · Cited by 179
Self-citationRőszer, T., Menéndez-Gutierrez, M. P., Lefterova, M. I., Alameda, D., Núñez, V., Lazar, M. A., Fischer, T., & Ricote, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002230 · Cited by 188
Self-citationKlotho is a target gene of PPAR-γ
Zhang, H., Li, Y., Fan, Y., Wu, J., Zhao, B., Guan, Y., Chien, S., & Wang, N. (2008) · Kidney International · doi:10.1038/ki.2008.244 · Cited by 175
Wiesner, P., Choi, S., Almazan, F., Benner, C. W., Huang, W. J. M., Diehl, C. J., Gonen, A., Butler, S. S., Witztum, J. L., Glass, C. K., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.218420 · Cited by 175
Self-citationXia, S., Sha, H., Liu, Y., Ji, Y., Ostrand‐Rosenberg, S., & Qi, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237123 · Cited by 169
Recurrent pregnancy loss: A disease of inflammation and coagulation
Kwak-Kim, J. Y.-H., Yang, K. M., & Gilman‐Sachs, A. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01079.x · Cited by 171
Gautier, E. L., Chow, A. T., Spanbroek, R., Marcelin, G., Greter, M., Jakubzick, C., Bogunovic, M., Leboeuf, M., van Rooijen, N., Habenicht, A. J. R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200495 · Cited by 175
Alisi, A., Carpino, G., de Oliveira, F. L., Panera, N., Nobili, V., & Gaudio, E. (2017) · Mediators of Inflammation · doi:10.1155/2017/8162421 · Cited by 172
The immune system's involvement in obesity-driven type 2 diabetes
Shu, C. J., Benoist, C. O., & Mathis, D. J. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.001 · Cited by 170
Renin‐Angiotensin‐Aldosterone System in Diabetes and Hypertension
Hsueh, W. A., & Wyne, K. L. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00449.x · Cited by 166
Kiss, M., Czimmerer, Z., & Nagy, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.044 · Cited by 166
Shao, M., Vishvanath, L., Busbuso, N. C., Hepler, C., Shan, B., Sharma, A. X., Chen, S., Yu, X., An, Y., Zhu, Y. Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03196-x · Cited by 166
Lee, J. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0023-8 · Cited by 161
Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
Lü, J., Zhao, J., Meng, H., & Zhang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01173 · Cited by 164
Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77
Chao, L. C., Wroblewski, K., Zhang, Z., Pei, L., Vergnes, L., Ilkayeva, O. R., Ding, S. Y., Reue, K., Watt, M. J., Newgard, C. B., et al. (2009) · Diabetes · doi:10.2337/db09-0763 · Cited by 154
Self-citationIto, A., Suganami, T., 山内, 明., Degawa‐Yamauchi, M., Tanaka, M., Kouyama, R., Kobayashi, Y., Nitta, N., Yasuda, K., Hirata, Y., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804220200 · Cited by 156
Adipose tissue macrophages as potential targets for obesity and metabolic diseases
Li, X., Ren, Y., Chang, K.-W., Wu, W., Griffiths, H. R., Lu, S., & Gao, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1153915 · Cited by 181
PPARγ in the endothelium regulates metabolic responses to high-fat diet in mice
Kanda, T., Brown, J. D., Orasanu, G., Vogel, S., Gonzalez, F. J., Sartoretto, J. L., Michel, T. M., & Plutzky, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36233 · Cited by 160
Self-citationSarruf, D. A., Yu, F. Z., Hồng, N. T., Williams, D. L., Printz, R. L., Niswender, K. D., & Schwartz, M. W. (2008) · Endocrinology · doi:10.1210/en.2008-0899 · Cited by 152
Palmitoylethanolamide in CNS health and disease
Raso, G. M., Russo, R., Calignano, A., & Meli, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.006 · Cited by 153
Adipose tissue recruitment of leukocytes
Anderson‐Baucum, E. K., Gutierrez, D. A., & Hasty, A. H. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283393867 · Cited by 156
Beaven, S. W., Matveyenko, A. V., Wroblewski, K., Chao, L. C., Wilpitz, D. C., Hsu, T. W., Lentz, J., Drew, B. G., Hevener, A. L., & Tontonoz, P. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.021 · Cited by 145
Self-citationDrew, B. G., Ribas, V., Le, J. A., Henstridge, D. C., Phun, J., Zhou, Z., Soleymani, T., Daraei, P., Sitz, D., Vergnes, L., et al. (2014) · Diabetes · doi:10.2337/db13-0665 · Cited by 145
Self-citationMacrophages, Meta-Inflammation, and Immuno-Metabolism
Shapiro, H., Lutaty, A., & Ariel, A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/397971 · Cited by 153
TLE3 Is a Dual-Function Transcriptional Coregulator of Adipogenesis
Villanueva, C. J., Waki, H., Godio, C., Nielsen, R., Chou, W.-L., Vargas, L., Wroblewski, K., Schmedt, C., Chao, L. C., Boyadjian, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.014 · Cited by 144
Self-citationMechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Orliaguet, L., Dalmas, É., Drareni, K., Venteclef, N., & Alzaïd, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00062 · Cited by 151
The many faces of PPARγ: Anti-inflammatory by any means?
Szántó, A., & Nagy, L. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.015 · Cited by 146
PPARγ is a nexus controlling alternative activation of macrophages via glutamine metabolismPreprint
Nelson, V. L., Nguyen, H. C. B., García‐Cañaveras, J. C., Briggs, E. R., Ho, W. Y., DiSpirito, J. R., Marinis, J. M., Hill, D. A., & Lazar, M. A. (2018) · Genes & Development · doi:10.1101/gad.312355.118 · Cited by 147
Kuda, O., Jelenik, T., Jilkova, Z., Flachs, P., Rossmeisl, M., Hensler, M., Kazdova, L., Ogston, N., Baranowski, M., Gorski, J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1305-z · Cited by 142
Innate immune activation in obesity
Lumeng, C. N.-K. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.002 · Cited by 147
Macrophage Content in Subcutaneous Adipose Tissue
de Victoria, E. O. M., Xu, X., Koška, J., Francisco, A. M. O., Scalise, M., Ferrante, A. W., & Krakoff, J. A. (2008) · Diabetes · doi:10.2337/db08-0536 · Cited by 146
Liver X receptors as regulators of macrophage inflammatory and metabolic pathways
A-González, N., & Castrillo, A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.015 · Cited by 139
Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance
Huang, W. J. M., & Glass, C. K. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191189 · Cited by 142
Self-citationNecela, B. M., Su, W., & Thompson, E. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02849.x · Cited by 140
Fan, W., Imamura, T., Sonoda, N., Sears, D. D., Patsouris, D., Kim, J. J., & Olefsky, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808915200 · Cited by 133
Self-citationPoulsen, M. M., Fjeldborg, K., Ørnstrup, M. J., Kjær, T. N., Nøhr, M. K., & Pedersen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.024 · Cited by 138
Revisiting PPARγ as a target for the treatment of metabolic disorders
Choi, S., Park, J., & Choi, J. H. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.11.174 · Cited by 143
Role of macrophage tissue infiltration in obesity and insulin resistance
Bourlier, V., & Bouloumié, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.05.001 · Cited by 141
Lipocalin 2 is a Regulator Of Macrophage Polarization and NF-κB/STAT3 Pathway Activation
Guo, H., Jin, D., & Chen, X. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1092 · Cited by 134
Regulation of Adipogenesis by Lymphatic Fluid Stasis
Aschen, S. Z., Zampell, J. C., Elhadad, S., Weitman, E. S., Brot, M. D., & Mehrara, B. J. (2012) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182450b47 · Cited by 126
Macrophage Polarization and Insulin Resistance: PPARγ in Control
Charo, I. F. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.07.006 · Cited by 129
PPARs: the vasculature, inflammation and hypertension
Duan, S. Z., Usher, M. G., & Mortensen, R. M. (2009) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328325803b · Cited by 121
Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver
Rogue, A., Spire, C., Brun, M., Claude, N., & Guillouzo, A. (2010) · PPAR Research · doi:10.1155/2010/325183 · Cited by 127
Fuentes, L., Rőszer, T., & Ricote, M. (2010) · Mediators of Inflammation · doi:10.1155/2010/219583 · Cited by 122
Self-citationWestcott, D. J., DelProposto, J. B., Geletka, L. M., Wang, T., Singer, K., Saltiel, A. R., & Lumeng, C. N.-K. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20091333 · Cited by 113
PPARγ and its ligands: therapeutic implications in cardiovascular disease
Villacorta, L., Schopfer, F. J., Zhang, J., Freeman, B. Α., & Chen, Y. (2009) · Clinical Science · doi:10.1042/cs20080195 · Cited by 115
Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome
Prieur, X., Rőszer, T., & Ricote, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.017 · Cited by 121
Self-citationRole and function of macrophages in the metabolic syndrome
Bhargava, P., & Lee, C. (2012) · Biochemical Journal · doi:10.1042/bj20111708 · Cited by 117
Microparticles Release by Adipocytes Act as “Find-Me” Signals to Promote Macrophage Migration
Eguchi, A., Mulya, A., Lazić, M., Radhakrishnan, D., Berk, M. P., Povero, D., Górnicka, A., & Feldstein, A. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123110 · Cited by 116
Impaired estrogen receptor action in the pathogenesis of the metabolic syndrome
Hevener, A. L., Clegg, D. J., & Mauvais-Jarvis, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.020 · Cited by 112
Self-citationOliveira, A. G., Araújo, T. G., Carvalho, B. M., Guadagnini, D., Rocha, G. Z., Bagarolli, R. A., Carvalheira, J. B. C., & Saad, M. J. A. (2013) · Obesity · doi:10.1002/oby.20402 · Cited by 112
Vallerie, S. N., Furuhashi, M., Fucho, R., & Hotamışlıgil, G. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003151 · Cited by 110
Kim, B., Farruggia, C., Ku, C. S., Pham, T. X., Yang, Y. J., Bae, M., Wegner, C., Farrell, N., Harness, E., Park, Y., et al. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.01.006 · Cited by 112
Chen, H., Shi, R., Luo, B., Yang, X., Qiu, L., Xiong, J., Jiang, M., Liu, Y., Zhang, Z., & Wu, Y. (2015) · Cell Death and Disease · doi:10.1038/cddis.2014.544 · Cited by 108
Caputo, T., Gilardi, F., & Desvergne, B. (2017) · FEBS Letters · doi:10.1002/1873-3468.12742 · Cited by 112
Morán‐Salvador, E., Titos, E., Rius, B., González‐Périz, A., García‐Alonso, V., López‐Vicario, C., Miquel, R., Barak, Y., Arroyo, V., & Clària, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.06.023 · Cited by 114
Perivascular Adipose Tissue as a Relevant Fat Depot for Cardiovascular Risk in Obesity
da Costa, R. M., Neves, K. B., Tostes, R. C., & Lobato, N. S. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00253 · Cited by 108
Muscle insulin resistance: assault by lipids, cytokines and local macrophages
Kewalramani, G., Bilan, P. J., & Klip, A. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833aabd9 · Cited by 105
Adipocytes, Innate Immunity and Obesity: A Mini-Review
Blaszczak, A. M., Jalilvand, A., & Hsueh, W. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.650768 · Cited by 109
Talbot, N. A., Wheeler-Jones, C. P. D., & Cleasby, M. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.010 · Cited by 105
PPARs and the kidney in metabolic syndrome
Ruan, X. Z., Zheng, F., & Guan, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00152.2007 · Cited by 103
Targeted delivery of curcumin for treating type 2 diabetes
Maradana, M. R., Thomas, R., & O’Sullivan, B. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200791 · Cited by 102
Adipose tissue inflammation in glucose metabolism
Kammoun, H. L., Kraakman, M. J., & Febbraio, M. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9274-4 · Cited by 101
Self-citationHall, J. A., Ramachandran, D., Roh, H. C., DiSpirito, J. R., Belchior, T., Zushin, P. H., Palmer, C., Hong, S., Mina, A. I., Liu, B., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.016 · Cited by 102
Epigenetic codes of PPARγ in metabolic disease
Sugii, S., & Evans, R. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.007 · Cited by 102
Xu, H., Li, H., Woo, S., Kim, S.-M., Shende, V. R., Neuendorff, N., Guo, X., Guo, T., Qi, T., Pei, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.539601 · Cited by 98
A Novel Pathway of Insulin Sensitivity in Chromogranin A Null Mice
Gayen, J. R., Saberi, M., Schenk, S., Biswas, N., Vaingankar, S. M., Cheung, W. W., Najjar, S. M., O’Connor, D. T., Bandyopadhyay, G. K., & Mahata, S. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020636 · Cited by 98
The Role of PPAR-γ in Allergic Disease
Stark, J. M., Coquet, J. M., & Tibbitt, C. A. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01022-x · Cited by 103
SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation
Toubal, A., Clément, K., Fan, R., Ancel, P., Pelloux, V., Rouault, C., Veyrie, N., Hartemann, A., Treuter, E., & Venteclef, N. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64052 · Cited by 97
Nuclear receptors as drug targets for metabolic disease
Schulman, I. G. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.002 · Cited by 95
Miao, H., Ou, J., Ma, Y., Guo, F., Yang, Z., Wiggins, M., Liu, C., Song, W., Han, X., Wang, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.047 · Cited by 94
Yekollu, S. K., Thomas, R., & O’Sullivan, B. (2011) · Diabetes · doi:10.2337/db11-0275 · Cited by 94
Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells
Bilan, P. J., Samokhvalov, V., Koshkina, A., Schertzer, J. D., Samaan, M. C., & Klip, A. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903079314 · Cited by 88
Shabani, M., Sadeghi, A., Hosseini, H., Teimouri, M., Khorzoughi, R. B., Pasalar, P., & Meshkani, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-60185-1 · Cited by 91
Bumrungpert, A., Kalpravidh, R. W., Chuang, C., Overman, A., Martinez, K., Kennedy, A. J., & McIntosh, M. (2010) · Journal of Nutrition · doi:10.3945/jn.109.120022 · Cited by 87
Gregoire, F. M., Zhang, F., Clarke, H. J., Gustafson, T. A., Sears, D. D., Favelyukis, S., Lenhard, J. M., Rentzeperis, D., Clemens, L. E., Mu, Y., et al. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0473 · Cited by 85
Mandard, S., & Patsouris, D. (2013) · PPAR Research · doi:10.1155/2013/613864 · Cited by 84
Ren, K., Li, H., Zhou, H.-F., Liang, Y., Tong, M., Chen, L., Zheng, X.-L., & Zhao, G.-J. (2019) · Aging · doi:10.18632/aging.102498 · Cited by 83
The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
Porcuna, J., Mínguez-Martínez, J., & Ricote, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910573 · Cited by 82
Self-citationNuclear Mechanisms of Insulin Resistance
Kang, S., Tsai, L. T.-Y., & Rosen, E. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.002 · Cited by 84
N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic Benefit
Wang, Y., & Huang, F. (2015) · BioMed Research International · doi:10.1155/2015/581469 · Cited by 89
Thomas, A. W., Davies, N. A., Moir, H. J., Watkeys, L. J., Ruffino, J. S., Isa, S., Butcher, L., Hughes, M. G., Morris, K., & Webb, R. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00864.2011 · Cited by 81
Type 2 diabetes mellitus: pathogenesis and genetic diagnosis
Himanshu, D., Ali, W., & Wamique, M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00641-x · Cited by 97
The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 81
Adipose tissues as endocrine target organs
Lanthier, N., & Leclercq, I. A. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.07.002 · Cited by 82
A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer’s Disease
Gamba, P., Staurenghi, E., Testa, G., Giannelli, S., Sottero, B., & Leonarduzzi, G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00556 · Cited by 77
Nicholls, H. T., Kowalski, G. M., Kennedy, D. J., Risis, S., Zaffino, L. A., Watson, N., Kanellakis, P., Watt, M. J., Bobik, A., Bonen, A., et al. (2011) · Diabetes · doi:10.2337/db10-1353 · Cited by 79
Self-citationImmunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 73
Keratinocyte-derived Chemokine in Obesity
Neels, J. G., Badeanlou, L., Hester, K. D., & Samad, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018556 · Cited by 76
Westwell-Roper, C. Y., Nąckiewicz, D., Dan, M., & Ehses, J. A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.4 · Cited by 74
Serotonin Modulation of Macrophage Polarization: Inflammation and Beyond
Casas-Engel, M. D. L., & Corbí, A. L. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-07320-0_9 · Cited by 76
Hevener, A. L., Zhou, Z., Moore, T. M., Drew, B. G., & Ribas, V. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.013 · Cited by 72
Self-citationAdipose tissue macrophages: Regulators of adipose tissue immunometabolism during obesity
Nance, S. A., Muir, L. A., & Lumeng, C. N.-K. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101642 · Cited by 75
Marzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 75
Metadata
- Authors
- Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., Folian, B., Subramaniam, S., Gonzalez, F. J., Glass, C. K., & Ricote, M.
- Affiliations
- University of California San Diego (US)
- University of California System (US)
- The University of Melbourne (AU)
- Baker Heart and Diabetes Institute (AU)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1658-1669
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1868788
- OpenAlex
- W2131598118
- Cited by
- 459
- References
- 71
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 23 · 2017: 22 · 2016: 18 · 2015: 28 · 2014: 32 · 2013: 49 · 2012: 41
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Pfizer
- Takeda Pharmaceutical Company
- Ministerio de Economía y Competitividad
- National Institutes of Health (DK 074868, DK-063491, GM-069338)
- University of California, San Diego (DK063491)
- National Heart, Lung, and Blood Institute (P50HL056989, HL-56989)
- National Institute of General Medical Sciences (U54GM069338, GM 069338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, DK 074868, DK 60484, DK-33651, K01DK060484, R37DK033651, R21DK073227, P01DK074868, DK73227, R01DK033651, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PPARγ, macrophages, thiazolidinediones, insulin resistance, insulin sensitivity, skeletal muscle, liver, adipose tissue, impaired glucose tolerance, inflammation, insulin signaling, fatty acids, high-fat diet, antidiabetic drugs
- MeSH terms
- Animals, Base Sequence, Hypoglycemic Agents, Insulin Resistance, Liver, Macrophages, Mice, Transgenic, Promoter Regions, Genetic, Adipocytes, DNA Primers, Mice, Knockout, Muscle, Skeletal, Gene Expression Profiling, Thiazolidinediones, PPAR gamma, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review